Similar effects of resistin and high glucose on P-selectin and fractalkine expression and monocyte adhesion in human endothelial cells

Biochemical and Biophysical Research Communications

Volumn 391, Issue 3, 2010, Pages 1443-1448

  Manduteanu, Ileana ^a   Pirvulescu, Monica ^a   Gan, Ana Maria ^a   Stan, Daniela ^a   Simion, Viorel ^a   Dragomir, Elena ^a   Calin, Manuela ^a   Manea, Adrian ^a   Simionescu, Maya ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

Author keywords

Fractalkine; High glucose; Monocyte adhesion; P selectin; Resistin

Indexed keywords

FRACTALKINE; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PADGEM PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RESISTIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; UPREGULATION;

BLOOD GLUCOSE; CELL ADHESION; CELL LINE; CHEMOKINE CX3CL1; DIABETES MELLITUS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; HYPERGLYCEMIA; MONOCYTES; NADPH OXIDASE; NF-KAPPA B; P-SELECTIN; REACTIVE OXYGEN SPECIES; RESISTIN; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 73949125986     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.089     Document Type: Article

References (28)

1. Jung H.S., Park K., Cho S., Park K., et al. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc. Res. 69 (2006) 76-85
2. Reilly M.P., Lehrike M., Lazar M.A., et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111 (2005) 932-939
3. Hui-bing H., Migita K., Kimura H., et al. Relationship between serum resistin concentrations and inflammatory markers in patients with type 2 diabetes mellitus. Metabolism 55 (2006) 1670-1673
4. Osawa H., Ochi M., Tabara Y., et al. Serum resistin is positively correlated with accumulation of metabolic syndrome factors in type 2 diabetes. Clin. Endocrinol. 69 (2008) 74-80
5. Simionescu M. Implications of early structural-functional changes in the endothelium for vascular disease. Arter. Thromb. Vasc. Biol. 27 (2007) 266-274
6. Altannavch T.S., Roubalova K., Kucera P., and Andel M. Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with or without Cytokine activation. Physiol. Res. 53 (2004) 77-82
7. Manduteanu I., Voinea M., Serban G., and Simionescu M. High glucose concentrations enhance monocyte adhesion to valvular endothelial cells via a mechanism involving ICAM-1, VCAM-1 and CD18. Endothelium 6 (1999) 315-324
8. Dragomir E., Voinea M., Simionescu M., et al. Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentrations in human endothelial cells. Vasc. Pharmacol. 44 (2006) 440-449
9. Kawanami D., Maemura K., Nagai R., et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-EC interaction. Biochem. Biophys. Res. Commun. 314 (2004) 415-419
10. Verma S., Li S.H., Wang C.H., Fedak P.W., et al. Resistin promotes EC activation: further evidence of adipokine-endothelial interaction. Circulation 108 (2003) 736-740
11. Manduteanu I., Dragomir E., Calin M., Pirvulescu M., Gan A.M., Stan D., and Simionescu M. Resistin up-regulates Fractalkine expression in human endothelial cells; lack of additive effect with TNF-α. Biochem. Biophys. Res. Commun. 381 (2009) 96-101
12. Muniandy S., Qvist R., and Yan G.O. The oxidative stress of hyperglycemia and the inflammatory process in endothelial cells. J. Med. Invest. 56 (2009) 6-10
13. Manduteanu I., Voinea M., Simionescu M., et al. Effect of enoxaparin on high glucose-induced activation of endothelial cells. Eur. J. Pharmacol. 477 (2003) 269-276
14. Schultz C., Schafer A., Stolla M., et al. Chemokine Fk, mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-sel expressed on activated platelets. Circulation 116 (2007) 764-773
15. Wong B.W.C., Wong D., and McManus B.M. Characterization of Fk (CXCL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease. Cardiovasc. Pathol. 11 (2002) 332-338
16. Woollard K.J., and Chin-Dusting J. Therapeutic targeting of P-sel in atherosclerosis. Inflamm. Allergy Drug Targets 6 (2006) 69-74
17. Puente Navazo M.D., Chettab K., Duhault J., Koenig-Berard E., and McGregor J.L. Glucose and insulin modulate the capacity of endothelial cells (HUVEC) to express P-sel and bind a monocytic cell line (U937). Thromb. Haemost. 86 (2001) 680-685
18. Aref S., Sakrana M., Hafez A.A., and Hamdy M. Soluble P-sel levels in diabetes mellitus patients with coronary artery disease. Hematology 10 (2005) 183-187
19. Hempel S.L., Bultner G.R., Malley Y.Q., et al. Dihydroflorescein diacetate is superior for detecting intracellular oxidants: Comparison with 2′,7′-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic. Biol. Med. 127 (1999) 146-159
20. Zhang Z., Apase K., Pang J., and Santon R.C. High glucose inhibits glucose-6-phosphate dehidrogenase via cAMP in aortic endothelial cells. J. Biol. Chem. 273 (2000) 40012-40017
21. Kunnari A.M., Savolainen E.R., Jokela M.A., et al. The expression of human resistin in different leukocyte lineages is modulated by LPS and TNF-α. Regul. Pept. 157 (2009) 57-63
22. Lehrke M., Reilly M.P., Lazar M.A., et al. An inflammatory cascade leading to hyperresistemia in humans. PLoS Med. 1 (2004) e45
23. Burnett M.S., Lee C.W., Epstein S.E., et al. The potential role of resistin in atherogenesis. Atherosclerosis 182 (2005) 241-248
24. Booth G., Thimothy J., Scalia R., et al. Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am. J. Physiol. Endocrinol. Metab. 280 (2001) E848-E856
25. Kashiwagi A., Asahina T., Shigeta Y., et al. Glycation, oxidative stress, and scavenger activity: glucose metabolism and radical scavenger dysfunction in endothelial cells. Diabetes 45 (1996) 84-86
26. 2-induced activation of human endothelial cells by a mechanism involving cell adhesion molecules and nuclear transcription factors. Pharmacology 79 (2007) 154-162
27. Lijun B., Pan J., McEver R.P., et al. A proteasome inhibitor, an antioxidant, or a salicylate, but not a glucocorticoid blocks constitutive and cytokine-inducible expression of P-selectin in human endothelial cells. Blood 91 (1998) 1625-1632
28. Kinishita K., Furukawwa M., Tarijoh K., et al. Acceleration of chemokine production from endothelial cells in response to lipopolysaccaride in hyperglycemic conditions. Acta Neurochir. 96 (2006) 419-421